Journal of Surgical Research
Volume 172, Issue 1 , Pages 116-122 , January 2012

Vitamin D Binding Protein-Macrophage Activating Factor Inhibits HCC in SCID Mice

  • Koichi Nonaka, M.D.

      Affiliations

    • Clinical Research Center, National Hospital Organization Nagasaki Medical Center, Department of Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Omura, Japan
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Clinical Research Center and Department of Surgery, National Nagasaki Medical Center, 2-1001-1 Kubara, Omura, 856-8652, Japan.
    • ,
  • Shinya Onizuka, M.D., Ph.D.

      Affiliations

    • Clinical Research Center, National Hospital Organization Nagasaki Medical Center, Department of Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Omura, Japan
    • ,
  • Hiromi Ishibashi, M.D., Ph.D.

      Affiliations

    • Clinical Research Center, National Hospital Organization Nagasaki Medical Center, Department of Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Omura, Japan
    • ,
  • Yoshihiro Uto, Ph.D.

      Affiliations

    • Department of Life System, Institute of Technology and Science, University of Tokushima Graduate School, Tokushima, Japan
    • ,
  • Hitoshi Hori, Ph.D.

      Affiliations

    • Department of Life System, Institute of Technology and Science, University of Tokushima Graduate School, Tokushima, Japan
    • ,
  • Toshiyuki Nakayama, M.D., Ph.D.

      Affiliations

    • Department of Pathology, Atomic Bomb Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
    • ,
  • Nariaki Matsuura, M.D., Ph.D.

      Affiliations

    • Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Osaka, Japan
    • ,
  • Takashi Kanematsu, M.D., Ph.D.

      Affiliations

    • Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
    • ,
  • Hikaru Fujioka, M.D., Ph.D.

      Affiliations

    • Clinical Research Center, National Hospital Organization Nagasaki Medical Center, Department of Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Omura, Japan

Received 12 June 2010 ,Accepted 28 July 2010.

References 

  1. Caldwell S, Park SH. The epidemiology of hepatocellular cancer: From the perspectives of public health problem to tumor biology. J Gastroenterol. 2009;44(Suppl 19):96
  2. Chen XP, Qiu FZ, Wu ZD, et al. Long-term outcome of resection of large hepatocellular carcinoma. Br J Surg. 2006;93:600
  3. Knight SR, Friend PJ, Morris PJ. Role of transplantation in the management of hepatic malignancy. Br J Surg. 2007;94:1319
  4. Kobayashi K, Fujioka H, Yanaga K, et al. Underlying histological activity of hepatitis plays an important role for tumor recurrence after curative resection of hepatocellular carcinoma. Acta Medica Nagasakiensia. 2009;53:97
  5. Zimmerman MA, Ghobrial RM, Tong MJ, et al. Recurrence of hepatocellular carcinoma following liver transplantation: A review of preoperative and postoperative prognostic indicators. Arch Surg. 2008;143:182;discussion 188
  6. Rampone B, Schiavone B, Martino A, et al. Current management strategy of hepatocellular carcinoma. World J Gastroenterol. 2009;15:3210
  7. Li CY, Shan S, Huang Q, et al. Initial stages of tumor cell-induced angiogenesis: Evaluation via skin window chambers in rodent models. J Natl Cancer Inst. 2000;92:143
  8. Folkman J. Tumor angiogenesis: Therapeutic implications. N Engl J Med. 1971;285:1182
  9. Ishii Y, Sakamoto T, Ito R, et al. Anti-angiogenic therapy on hepatocellular carcinoma development and progression. J Surg Res. 2008;
  10. Kisker O, Onizuka S, Becker CM, et al. Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice. Neoplasia. 2003;5:32
  11. Yamamoto N, Naraparaju VR. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor. Cancer Res. 1997;57:2187
  12. Nagasawa H, Uto Y, Sasaki H, et al. Gc protein (vitamin D-binding protein): Gc genotyping and GcMAF precursor activity. Anticancer Res. 2005;25:3689
  13. Link RP, Perlman KL, Pierce EA, et al. Purification of human serum vitamin D-binding protein by 25-hydroxyvitamin D3-Sepharose chromatography. Anal Biochem. 1986;157:262
  14. Yamamoto N, Homma S. Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes. Proc Natl Acad Sci USA. 1991;88:8539
  15. Bissell MJ. Tumor plasticity allows vasculogenic mimicry, a novel form of angiogenic switch. A rose by any other name?. Am J Pathol. 1999;155:675
  16. Jiang B, Morimoto S, Yang J, et al. Expression of parathyroid hormone/parathyroid hormone-related protein receptor in vascular endothelial cells. J Cardiovasc Pharmacol. 1998;31(Suppl 1):S142
  17. Merchan JR, Chan B, Kale S, et al. In vitro and in vivo induction of anti-angiogenic activity by plasminogen activators and captopril. J Natl Cancer Inst. 2003;95:388
  18. Onizuka S, Kawakami S, Taniguchi K, et al. Pancreatic carcinogenesis: Apoptosis and angiogenesis. Pancreas. 2004;28:317
  19. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol. 1995;147:9
  20. McKnight AJ, Macfarlane AJ, Dri P, et al. Molecular cloning of F4/80, a murine macrophage-restricted cell surface glycoprotein with homology to the G-protein-linked transmembrane 7 hormone receptor family. J Biol Chem. 1996;271:486
  21. Kanda S, Mochizuki Y, Miyata Y, et al. Effects of vitamin D(3)-binding protein-derived macrophage activating factor (GcMAF) on angiogenesis. J Natl Cancer Inst. 2002;94:1311
  22. Kalkunte S, Brard L, Granai CO, et al. Inhibition of angiogenesis by vitamin D-binding protein: Characterization of anti-endothelial activity of DBP-maf. Angiogenesis. 2005;8:349
  23. Yamaguchi R, Yano H, Iemura A, et al. Expression of vascular endothelial growth factor in human hepatocellular carcinoma. Hepatology. 1998;28:68
  24. Messerini L, Novelli L, Comin CE. Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma. J Clin Pathol. 2004;57:867
  25. Sparano JA, Gray R, Giantonio B, et al. Evaluating antiangiogenesis agents in the clinic: The Eastern Cooperative Oncology Group Portfolio of Clinical Trials. Clin Cancer Res. 2004;10:1206
  26. Siegel AB, Cohen EI, Ocean A, et al. Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma. J Clin Oncol. 2008;26:2992
  27. Thomas MB, Morris JS, Chadha R, et al. Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma. J Clin Oncol. 2009;27:843
  28. Tsuchiyama T, Nakamoto Y, Sakai Y, et al. Optimal amount of monocyte chemoattractant protein-1 enhances antitumor effects of suicide gene therapy against hepatocellular carcinoma by M1 macrophage activation. Cancer Sci. 2008;99:2075
  29. Li YW, Qiu SJ, Fan J, et al. Tumor-infiltrating macrophages can predict favorable prognosis in hepatocellular carcinoma after resection. J Cancer Res Clin Oncol. 2009;135:439
  30. Lin CY, Lin CJ, Chen KH, et al. Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction. FEBS Lett. 2006;580:3042
  31. Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002;23:549
  32. Mohamad SB, Nagasawa H, Sasaki H, et al. Gc protein-derived macrophage activating factor (GcMAF): Isoelectric focusing pattern and tumoricidal activity. Anticancer Res. 2003;23:4451
  33. O’Reilly MS, Holmgren L, Chen C, et al. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med. 1996;2:689
  34. Boehm T, Folkman J, Browder T, et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature. 1997;390:404

PII: S0022-4804(10)00673-6

doi: 10.1016/j.jss.2010.07.057

Journal of Surgical Research
Volume 172, Issue 1 , Pages 116-122 , January 2012

Article Tools

* Image Usage & Resolution